BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34217226)

  • 1. IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study.
    Meessen JMTA; Cesaroni G; Mureddu GF; Boccanelli A; Wienhues-Thelen UH; Kastner P; Ojeda-Fernandez L; Novelli D; Bazzoni G; Mangiavacchi M; Agabiti N; Masson S; Staszewsky L; Latini R;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):328. PubMed ID: 34217226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure.
    Jungbauer CG; Riedlinger J; Block D; Stadler S; Birner C; Buesing M; König W; Riegger G; Maier L; Luchner A
    Biomark Med; 2014; 8(6):777-89. PubMed ID: 25224934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
    Gandhi PU; Chow SL; Rector TS; Krum H; Gaggin HK; McMurray JJ; Zile MR; Komajda M; McKelvie RS; Carson PE; Januzzi JL; Anand IS
    J Card Fail; 2017 Jan; 23(1):20-28. PubMed ID: 27317843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
    Zhu ZD; Sun T
    Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
    Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea.
    Ibrahim NE; Afilalo M; Chen-Tournoux A; Christenson RH; Gaggin HK; Hollander JE; Kastner P; Levy PD; Mang A; Masson S; Nagurney JT; Nowak RM; Pang PS; Peacock WF; Dipl-Stat VR; Walters EL; Januzzi JL
    JACC Heart Fail; 2020 May; 8(5):415-422. PubMed ID: 32354416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
    Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
    ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
    Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
    Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?
    Gandhi PU; Gaggin HK; Sheftel AD; Belcher AM; Weiner RB; Baggish AL; Motiwala SR; Liu PP; Januzzi JL
    Am J Cardiol; 2014 Nov; 114(10):1543-9. PubMed ID: 25248814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
    Januzzi JL; Packer M; Claggett B; Liu J; Shah AM; Zile MR; Pieske B; Voors A; Gandhi PU; Prescott MF; Shi V; Lefkowitz MP; McMurray JJV; Solomon SD
    Circ Heart Fail; 2018 Oct; 11(10):e005133. PubMed ID: 30354399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
    Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
    Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Gaggin HK; Bhardwaj A; Januzzi JL
    J Cardiovasc Transl Res; 2014 Mar; 7(2):250-61. PubMed ID: 24309956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.